| 04/16/2025 11:00 |
Corporate Governance Report |
| 04/15/2025 15:30 |
Notice Regarding Disposal of Treasury Stock for Restricted-Stock-Based Compensation |
| 03/31/2025 15:30 |
Monthly Sales Report, March FY2025 |
| 03/25/2025 08:00 |
Notice of Convocation of the 50th Annual General Meeting of Shareholders |
| 03/21/2025 09:00 |
Establishment of the "DyDo GROUP Future Co-Creation Institute" for Enhancement of Research and Development Capability of the Group |
| 03/14/2025 15:30 |
Notice Regarding the Results of Evaluation of the Effectiveness of the Board of Directors |
| 03/04/2025 15:30 |
Summary of Financial Results 2025 |
| 03/04/2025 15:30 |
Notice Regarding the Commemorative Dividend for the 50th Anniversary |
| 03/04/2025 15:30 |
Notice Regarding the Revision of the Medium-Term Management Plan 2026 |
| 03/04/2025 15:30 |
FY2024 (Year Ended January 20, 2025) Financial Highlights |
| 03/04/2025 15:30 |
FY2024 (Year Ended January 20, 2025) Supplementary Material for Financial Results |
| 02/28/2025 15:30 |
Monthly Sales Report, February FY2025 |
| 01/31/2025 15:30 |
Monthly Sales Report, January FY2024 |
| 01/24/2025 15:30 |
(Updated) Notice of Results of the New Early Retirement Incentive Program |
| 12/27/2024 15:30 |
Monthly Sales Report, December FY2024 |
| 12/26/2024 13:10 |
Corporate Governance Report |
| 12/24/2024 00:30 |
DyDo Group Holdings Integrated Report 2024 |
| 12/17/2024 15:30 |
Notice Concerning a New Early Retirement Incentive |
| 11/29/2024 15:30 |
Monthly Sales Report, November FY2024 |
| 11/26/2024 15:30 |
Summary of Financial Results for the third quarter 2025 |
| 11/26/2024 15:30 |
FY2024(Year Ending January 20, 2025) 3rd Quarter Financial Highlights |
| 11/25/2024 15:30 |
Notice Regarding Completion of Payment and Partial Forfeiture of Rights for Disposal of Treasury Shares as Restricted Stock Incentives for ESA |
| 10/31/2024 15:00 |
Monthly Sales Report, October FY2024 |
| 09/30/2024 15:00 |
Monthly Sales Report, September FY2024 |
| 09/24/2024 15:00 |
Approval of New Drug Application (NDA) of Firdapse Tablet 10mg Acquired by Consolidated Subsidiary |
| 09/13/2024 16:45 |
Notice Regarding Disposal of Treasury Shares as Restricted Stock Incentives for Employee Shareholding Association |
| 08/30/2024 15:00 |
Monthly Sales Report, August FY2024 |
| 08/27/2024 15:00 |
Summary of Financial Results for the second quarter 2025 |
| 08/27/2024 15:00 |
Announcement of Consolidated Financial Forecasts for FY2024 |
| 08/27/2024 15:00 |
FY2024(Year Ending January 20, 2025) 2nd Quarter Financial Highlights |
| 07/31/2024 15:00 |
Monthly Sales Report, July FY2024 |
| 06/28/2024 15:00 |
Monthly Sales Report, June FY2024 |
| 05/31/2024 15:00 |
Monthly Sales Report, May FY2024 |
| 05/27/2024 15:00 |
Summary of Financial Results for the first quarter 2025 |
| 05/27/2024 15:00 |
FY2024 (Year Ending January 20, 2025) 1st Quarter Financial Highlights |
| 05/15/2024 15:00 |
Notice Regarding Completion of Payment for Disposal of Treasury Stock for Restricted-Stock-Based Compensation |
| 04/30/2024 15:00 |
Monthly Sales Report, April FY2024 |
